Lonza News 11. Feb. 2026 Lonza Group (OTCMKTS:LZAGY) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat
Lonza News 9. Feb. 2026 Speed-to-IND Starts with Toxicology: A Rapid-Fire Q&A with Lonza - BioPharm International
Lonza News 8. Feb. 2026 Lonza’s Strategic Pivot Fuels Robust Growth and Shareholder Returns - AD HOC NEWS
Lonza News 7. Feb. 2026 Lonza Issues Partially Unreadable Release, Leaving Details Unclear - TipRanks
Lonza News 6. Feb. 2026 Lonza Group (OTCMKTS:LZAGY) Rating Lowered to "Strong Sell" at Zacks Research - MarketBeat
Lonza News 4. Feb. 2026 Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News 4. Feb. 2026 Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News 3. Feb. 2026 Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY) - The Globe and Mail
Lonza News 3. Feb. 2026 45% earnings growth over 1 year has not materialized into gains for Lonza Group (VTX:LONN) shareholders over that period - Yahoo Finance
Lonza News 3. Feb. 2026 Earnings call transcript: Lonza misses Q4 2025 forecasts, stock drops 9% - Investing.com
Lonza News 2. Feb. 2026 Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - MSN
Lonza News 2. Feb. 2026 Lonza Group AG: The Silent Engine Powering the Next Wave of Biotech - AD HOC NEWS
Lonza News 30. Jan. 2026 Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - MSN
Lonza News 30. Jan. 2026 CDMOs dominate the headlines – and Lonza delivers a clear message of strength - European Biotechnology Magazine